Adrenomed

Adrenomed

Germany - Hennigsdorf
Biotechnology

Focus: Sepsis drug

Adrenomed is a life sciences company focused on Sepsis drug.

Infectious Diseases
Funding Stage
PUBLIC
Open Jobs
0

Pipeline & Clinical Trials

Phase 1
Clinical Trials (1)
NCT02991508Adrecizumab Phase 1 Trial
Phase 1
Phase 1
Clinical Trials (1)
NCT03083171Adrecizumab-LPS Study
Phase 1
Adrecizumab
Septic Shock
Phase 2
Clinical Trials (1)
NCT03085758Treatment of Patients With Early Septic Shock and Bio-Adrenomedullin(ADM) Concentration > 70 pg/ml With ADRECIZUMAB
Phase 2

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Founded: 2009
Portfolio: 3 clinical trials
Publications: 22 in PubMed